INTRAVASKULÄRE EINFÜHRVORRICHTUNGEN

European patent · EP3137146 · In force

Register entry

Publication number
EP3137146
Application number
EP15783950
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Apr 27, 2015
Published
Mar 8, 2017
Granted
Sep 1, 2021
Protection ends at the latest
Apr 26, 2035
Next annual fee due
Apr 30, 2027
IPC classes
A61M 25/00 (2006.01)
A61F 2/962 (2013.01)
A61F 2/95 (2013.01)
A61F 2/24 (2006.01)
Priority
US 201461985330 P 28.04.2014
US 201514695607 24.04.2015
PCT application
PCT/US2015/027764 27.04.2015
PCT publication
WO2015/168006 05.11.2015
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. May 1, 2026

    Change

    Published in Swissreg on 01.05.2026

  2. May 1, 2025

    Change

    Published in Swissreg on 01.05.2025

  3. May 1, 2024

    Change

    Published in Swissreg on 01.05.2024

  4. May 1, 2023

    Change

    Published in Swissreg on 01.05.2023

  5. Jul 13, 2022

    Change

    Published in Swissreg on 13.07.2022

  6. Sep 1, 2021

    Granted

    Published in Swissreg on 01.09.2021

Parties

Holder

Edwards Lifesciences Corporation

One Edwards Way, Irvine, CA 92614, US

Inventor

LE, Thanh Huy

Irvine, CA 92614, US

RAFI, Hamid

Irvine, CA 92614, US

FROIMOVICH ROSENBERG, Alejandro J.

Irvine, CA 92614, US

LE, Tung T.

Irvine, CA 92614, US

SARAVIA, Maria L.

Irvine, CA 92614, US

BOWES, Robert

Irvine, CA 92614, US

TRINH, Uy D.

Irvine, CA 92614, US

TRAN, Sonny

Irvine, CA 92614, US

GRAY, Brian C.

Irvine, CA 92614, US

OIEN, Andrew

Irvine, CA 92614, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.